Skip to content

    Bicara Therapeutics (BCAX) stock price & financials

    View BCAX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+94.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    Operating Profit
    -$20.63M
    -$26.64M
    -$41.79M
    -$32.02M
    -$40.68M
    -97.2%
    -$41.12M
    -54.4%
    -$60.24M
    -44.2%
    -$59.95M
    -87.2%
    Weakening
    Net Profit
    -$17.48M
    -$20.96M
    -$36.85M
    -$27.39M
    -$36.33M
    -107.8%
    -$37.39M
    -78.4%
    -$56.21M
    -52.6%
    -$55.44M
    -102.4%
    Weakening
    EPS
    $-1.60
    $-0.68
    $-0.50
    $-0.67
    +58.1%
    $-0.93
    -36.8%
    $-0.82
    -64.0%
    Weakening
    Other Income
    $3.15M
    $5.87M
    $5.01M
    $4.68M
    $4.39M
    +39.4%
    $3.79M
    -35.4%
    $4.08M
    -18.6%
    $4.58M
    -2.3%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    -$17.48M
    -$20.77M
    -$36.77M
    -$27.34M
    -$36.29M
    -107.6%
    -$37.33M
    -79.7%
    -$56.16M
    -52.7%
    -$55.38M
    -102.6%
    Weakening
    MarginsOPM
    Tax
    0.0%
    -0.9%
    -0.2%
    -0.2%
    -0.1%
    -0.1%
    +84.4%
    -0.1%
    +55.0%
    -0.1%
    +42.1%
    Strengthening
    ReturnsROIC
    2.0%
    2.4%
    4.2%
    3.1%
    4.2%
    +107.8%
    4.3%
    +78.4%
    6.5%
    +52.6%
    6.4%
    +102.4%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY23FY24FY25TTM
    AssetsCash & Equivalents$230.44M$489.71M$96.69M$96.60M
    Short-Term Investments$318.12M$400.66M
    Total Current Assets$231.07M$502.53M$422.05M$503.82M
    Net PP&E$815.0K$845.0K$2.03M$1.51M
    Goodwill
    Intangibles
    Total Assets$233.98M$510.00M$430.99M$512.24M
    LiabilitiesTotal Current Liabilities$15.09M$17.99M$28.95M$43.48M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$372.0K$131.0K$593.0K$0
    Total Liabilities$15.47M$18.12M$29.54M$43.48M
    EquityCommon Stock & APIC$2.0K$7.0K$7.0K$8.0K
    Retained Earnings-$153.02M-$221.02M-$358.97M-$470.61M
    Total Equity-$148.77M$491.88M$401.45M$468.77M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY23FY24FY25TTM
    ActivitiesCash from Operating-$45.63M-$74.75M-$106.83M-$134.85M
    Cash from Investing-$586.0K-$9.0K-$318.45M-$402.50M
    Cash from Financing$272.50M$334.03M$32.26M$197.34M
    SummaryCapital Expenditure-$586.0K-$71.0K-$280.0K-$400.0K
    Free Cash Flow-$46.21M-$74.82M-$107.11M-$135.25M
    FCF Margin

    Ratios